AMGN compared with TARA: revenue, margins and what each company keeps, and the suppliers and customers both name

AMGNAmgen Inc

Mkt capRevenueRevenue

TARAProtara Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

AMGNAmgen Inc

TARAProtara Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

AMGNAmgen Inc

461.49▼−3.55%· post 460.23· delayed

Mkt cap$258.8BRevenue$10.4BQ3 FY26Revenue$36.8BFY25

TARAProtara Therapeutics, Inc.

2.13▼−9.34%· post 2.17· delayed

After hoursNov 5 '26delayed

Mkt cap$143.4MRevenue—Revenue—

Compare

After hoursNov 5 '26delayed

AMGNAmgen Inc

TARAProtara Therapeutics, Inc.

461.49▼−3.55%post 460.23delayed

Price

2.13▼−9.34%post 2.17delayed

$258.8B

Mkt cap

$143.4M

Q3 FY26$10.4B

Revenue

—

FY25$36.8B

Revenue

—

AMGN461.49▼−3.55%vsTARA2.13▼−9.34%After hoursNov 5 '26delayed

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only AMGN 12

PODDInsuletsupplier

CYTKCytokineticssupplier

ARWRArrowhead Pharmaceuticalssupplier

LGNDLigand Pharmaceuticalssupplier

8 more · AMGN chain ›

Shared 0

No disclosed counterparties: TARA.

Only TARA 0

None

Role chip = supplier or customerSource: SEC EDGAR